FEAV Seeks Shareholder Nod for Director Equity, Warrant Issuance

TL;DR

**FEAV is pushing for major equity moves to fund operations and align director incentives; vote FOR if you believe in the long-term vision, but be ready for dilution.**

AI Summary

5E Advanced Materials, Inc. (FEAV) is holding its 2025 Annual Meeting on December 8, 2025, to address several critical proposals impacting its governance and equity structure. Key proposals include the election of four directors—Graham van't Hoff, Curtis Hbert, Barry Dick, and Bryn Jones—to serve until the 2026 Annual Meeting. The company also seeks ratification of PricewaterhouseCoopers LLP as its independent auditor for fiscal year 2026. Significantly, FEAV is requesting approval for the participation of the four named directors in the Amended and Restated 2022 Equity Compensation Plan, alongside an amendment to increase the number of shares authorized for issuance under this plan. Furthermore, the company is seeking approval for issuing warrants to BEP Special Situations IV LLC and Ascend Global Investment Fund SPC, and for the subsequent issuance of common stock upon exercise of these warrants, in compliance with ASX and Nasdaq listing rules. These equity-related proposals suggest a strategic move to incentivize leadership and potentially raise capital, while the virtual meeting format aims to enhance stockholder access.

Why It Matters

This DEF 14A filing is crucial for 5E Advanced Materials, Inc. as it outlines significant governance and capital structure changes. Approving director participation in the equity plan and increasing authorized shares could dilute existing shareholder value but also align director incentives with long-term company performance. The proposed warrant issuance to BEP Special Situations IV LLC and Ascend Global Investment Fund SPC indicates a potential capital infusion or strategic partnership, which could be vital for the company's operational funding and growth in the competitive advanced materials sector. Investors need to weigh the benefits of incentivized leadership and potential capital against the immediate dilution effects, while employees and customers will watch for stability and growth signals.

Risk Assessment

Risk Level: medium — The filing indicates a medium risk level due to multiple proposals involving significant equity dilution and potential capital raises. Specifically, Proposal Four seeks to increase the number of shares authorized for issuance under the 2022 Equity Compensation Plan, and Proposals Five and Six involve issuing new warrants and common stock upon their exercise to BEP Special Situations IV LLC and Ascend Global Investment Fund SPC. These actions could dilute existing shareholder ownership and impact the stock price.

Analyst Insight

Investors should carefully review Proposals Three, Four, Five, and Six, which involve director equity participation, increased share authorization, and warrant issuance. Consider voting 'FOR' if you believe these measures are necessary for capital formation and aligning management incentives, but be prepared for potential short-term share dilution. Engage with the virtual meeting to ask questions about the specifics of the warrant agreements.

Financial Highlights

debt To Equity

N/A

revenue

$22,444,587

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Executive Compensation

Key Numbers

• 22,444,587 — Shares of common stock outstanding (As of the Record Date, October 14, 2025)
• 10 — CDIs per common stock share (Ratio for beneficial ownership and voting rights for CDI holders)
• 4 — Directors to be elected (Graham van't Hoff, Curtis Hbert, Barry Dick, and Bryn Jones)
• 7 — Proposals to be voted on (Excluding 'other business')
• 2025-10-14 — Record Date (Eligibility for voting at the Annual Meeting)
• 2025-12-08 — Annual Meeting Date (Date of the virtual Annual Meeting of Stockholders)
• 10:00 a.m. Pacific time — Annual Meeting Time (Start time for the virtual Annual Meeting)
• 90 days — Recording availability (Duration the meeting recording will be available at meetnow.global/M2PAGMQ)
• 15 minutes — Question answering time (Maximum time allocated for stockholder questions during the virtual meeting)
• 15-digit — Control number length (Required for stockholders to log in and vote at the virtual meeting)

Key Players & Entities

• 5E Advanced Materials, Inc. (company) — Registrant
• Graham van't Hoff (person) — Director nominee and participant in equity plan
• Curtis Hbert (person) — Director nominee and participant in equity plan
• Barry Dick (person) — Director nominee and participant in equity plan
• Bryn Jones (person) — Director nominee and participant in equity plan
• PricewaterhouseCoopers LLP (company) — Independent registered public accounting firm
• BEP Special Situations IV LLC (company) — Recipient of warrants to purchase common stock
• Ascend Global Investment Fund SPC (company) — Recipient of warrants to purchase common stock
• Joshua Malm (person) — Chief Financial Officer, Treasurer and Corporate Secretary
• SEC (regulator) — Securities and Exchange Commission

FAQ

Risk Factors

• ASX and Nasdaq Listing Rule Compliance [high — regulatory]: The company is seeking approval for warrant issuances and subsequent stock issuances upon exercise, which require compliance with ASX Listing Rule 10.14 and 10.11, and Nasdaq listing rules. Failure to obtain these approvals could impact the company's ability to execute strategic financing and equity-based incentive plans.
• Equity Dilution from Warrant Exercise [medium — financial]: Approval is sought for the issuance of warrants to BEP Special Situations IV LLC and Ascend Global Investment Fund SPC, and for the subsequent issuance of common stock upon exercise. This could lead to significant dilution of existing shareholders' equity if the warrants are exercised.
• Dependence on Equity Compensation Plan [medium — operational]: The company is proposing to approve director participation and increase the share pool for the Amended and Restated 2022 Equity Compensation Plan. This highlights a reliance on equity-based incentives for management and potentially other employees, which could be impacted by market conditions or shareholder sentiment.
• Stockholder Approval for Key Proposals [high — legal]: Several critical proposals, including director elections, auditor ratification, equity plan amendments, and warrant issuances, require stockholder approval. Insufficient votes could necessitate adjournment, impacting the company's strategic timeline and governance.

Industry Context

5E Advanced Materials, Inc. operates in the advanced materials sector, focusing on critical minerals like boron. The industry is characterized by increasing demand for materials essential for renewable energy, electric vehicles, and advanced manufacturing. Competition often involves securing reliable supply chains and navigating complex extraction and processing technologies.

Regulatory Implications

The company faces significant regulatory scrutiny related to its equity issuances, requiring adherence to both ASX and Nasdaq listing rules. Obtaining necessary shareholder approvals is critical to avoid delays or cancellations of strategic financing and incentive programs.

What Investors Should Do

1. Review director nominees and their alignment with company strategy.
2. Evaluate the potential dilution from proposed warrant issuances.
3. Understand the proposed amendments to the 2022 Equity Compensation Plan.
4. Vote on the ratification of PricewaterhouseCoopers LLP as the independent auditor.

Key Dates

• 2025-10-14: Record Date — Establishes eligibility for stockholders to vote at the 2025 Annual Meeting.
• 2025-12-08: 2025 Annual Meeting of Stockholders — Date for voting on critical governance and equity structure proposals, including director elections and equity plan amendments.
• 2026-06-30: Fiscal Year End — The independent auditor, PricewaterhouseCoopers LLP, is being ratified for this fiscal year.

Glossary

CDI

CHESS Depositary Interests. These represent underlying shares of common stock but are traded on the ASX. For FEAV, 10 CDIs are equivalent to one common stock share. (Important for understanding voting rights and ownership structure for Australian investors.)

DEF 14A

A proxy statement filing required by the SEC for companies holding annual meetings. It details information about the meeting, proposals, directors, and executive compensation. (This document provides the basis for the analysis of the company's governance and strategic proposals.)

Warrants

Financial instruments that give the holder the right, but not the obligation, to purchase a company's stock at a specified price (exercise price) within a certain timeframe. (The company is seeking approval to issue warrants, which could lead to future stock issuance and potential dilution.)

Amended and Restated 2022 Equity Compensation Plan

A company plan that allows for the issuance of stock options, restricted stock units, and other equity-based awards to employees, directors, and consultants. (Key proposals involve director participation and increasing the share pool for this plan, indicating a focus on equity incentives.)

Year-Over-Year Comparison

This filing focuses on the upcoming 2025 Annual Meeting and proposals related to governance, director elections, and significant equity issuances, including warrants and amendments to the equity compensation plan. Specific comparative financial metrics to a prior filing are not detailed within this proxy statement, but the proposals themselves indicate strategic moves to potentially raise capital and incentivize management.

Key Financial Figures

• $0.01 — 4,587 shares of common stock, par value $0.01 per share, were outstanding. Only holde

Filing Documents

• feam-20251024.htm (DEF 14A) — 1301KB
• img213470084_0.jpg (GRAPHIC) — 319KB
• img213470084_1.jpg (GRAPHIC) — 95KB
• img213470084_2.jpg (GRAPHIC) — 35KB
• img213470084_3.jpg (GRAPHIC) — 93KB
• img213470084_4.jpg (GRAPHIC) — 70KB
• img213470084_5.jpg (GRAPHIC) — 1331KB
• img213470084_6.jpg (GRAPHIC) — 978KB
• img213470084_7.jpg (GRAPHIC) — 1006KB
• img213470084_8.jpg (GRAPHIC) — 1230KB
• 0001193125-25-250705.txt ( ) — 13603KB
• feam-20251024.xsd (EX-101.SCH) — 7KB
• feam-20251024_htm.xml (XML) — 4KB

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS 4 PROXY STATEMENT SUMMARY 5 PROXY STATEMENT 6 QUESTIONS AND ANSWERS 7 MATTERS TO BE CONSIDERED AT ANNUAL MEETING 17 PROPOSAL ONE (1) TO (4) – ELECTION OF DIRECTORS 17 CORPORATE GOVERNANCE 20 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 25

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 28 EXECUTIVE OFFICERS 30 EXEUCTIVE COMPENSATION 31 SECURITIES AUTHORIZED FOR ISSANCE UNDER EQUITY COMPENSATION PLANS 37 PROPOSAL TWO – RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2026 38 REPORT OF THE AUDIT COMMITTEE 40 PROPOSAL THREE (1) TO (4) – TO APPROVE, FOR PURPOSES OF ASX LISTING RULE 10.14 AND FOR ALL OTHER PURPOSES, PARTICIPATION BY THE DIRECTORS IN THE COMPANY'S AMENDED AND RESTATED 2022 EQUITY COMPENSATION PLAN 41 PROPOSAL FOUR – TO APPROVE AN AMENDMENT TO THE AMENDED AND RESTATED 5E ADVANCED MATERIALS, INC. 2022 EQUITY COMPENSATION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE 44 PROPOSAL FIVE – TO APPROVE, INCLUDING FOR THE PURPOSES OF ASX LISTING RULE 10.11 AND FOR ALL OTHER PURPOSES, OF OUR ENTRY INTO AN AGREEMENT TO ISSUE WARRANTS TO PURCHASE COMMON STOCK TO BEP SPECIAL SITUATIONS IV LLC AND ASCEND GLOBAL INVESTMENT FUND SPC FOR AND ON BEHALF OF STRATEGIC SP, OR THEIR RESPECTIVE AFFILIATES, AS DESCRIBED HEREIN 52 PROPOSAL SIX – TO APPROVE, FOR PURPOSES OF NASDAQ LISTING RULES, THE ISSUANCE OF SHARES OF OUR COMMON UPON EXERCISE OF THE PROPOSED NEW WARRANTS, AS DESCRIBED HEREIN 55 PROPOSAL SEVEN – TO APPROVE THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF PROPOSALS THREE, FOUR, FIVE OR SIX 56 APPENDIX A – PROPOSED AMENDMENT TO THE AMENDED AND RESTATED 5E ADVANCED MATERIALS, INC.2022 EQUITY COMPENSATION PLAN A- 1 APPENDIX B – AMENDED AND RESTATED 5E ADVANCED MATERIALS, INC. 2022 EQUITY COMPENSATION PLAN B- 1 3

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Proxy Statement contains various forward-looking statements that are not historical facts. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "intend," "budget," "target," "aim," "strategy," "estimate," "plan," "guidance," "outlook," "may," "should," "could," "will," "would," "will be," "will continue," "will likely result," and similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements reflect the Company and management's beliefs and expectations based on current estimates and projections. While the Company believes these expectations, and the estimates and projections on which they are based, are reasonable and were made in good faith, these statements are subject to numerous risks and uncertainties, any of which could cause the Company's actual results, performance, or achievements, or industry results, to differ materially from any future results, performance, or achievements expressed or implied by such forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which include, but are not limited to, the risks described in the Company's Annual Report on Form 10-K for the year ended June 30, 2025, under the heading "Risk Factors" and in other documents filed by the Company with the Securities and Exchange Commission (the "SEC"). These forward-looking statements speak only as of the date hereof, and except as required by law, the Company undertakes no obligation to correct, update, or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary

View Full Filing

View this DEF 14A filing on SEC EDGAR